Demographic and clinical predictors of high healthcare use in patients with inflammatory bowel disease

Benjamin Click, Claudia Ramos Rivers, Ioannis E. Koutroubakis, Dmitriy Babichenko, Alyce M. Anderson, Jana G. Hashash, Michael A. Dunn, Marc Schwartz, Jason Swoger, Leonard Baidoo, Arthur Barrie, Miguel Regueiro, David G. Binion*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

68 Scopus citations


Background: Inflammatory bowel disease (IBD) is a heterogeneous chronic inflammatory condition requiring significant healthcare expenditure. Subgroups of individuals contribute disproportionately to spending. We aimed to determine demographic and clinical factors predictive of high healthcare expenditures for IBD patients followed over a multiyear period. Methods: This was a registry analysis using a prospective observational, consented, natural history registry from a tertiary IBD center and associated medical charges, not including pharmacy expenses. The 100 patients with the highest medical charges (top 5%) were compared with the median 300 patients. Logistic regression determined demographic and clinical factors associated with high charge patients. Results: IBD patients in the high charge group had significantly more unemployment (P < 0.0001), were of black race (P 0.013), comorbid psychiatric illness (P 0.002), hypertension (P 0.01), diabetes (P 0.004), opiate use (P < 0.0001), perianal involvement (P 0.002), penetrating disease (P < 0.0001), and extensive colitis (P 0.01). In multivariate analysis, unemployment (Crohn's disease [CD]: odds ratio [OR], 3.04; 95% confidence interval [CI], 1.32-7.02; ulcerative colitis [UC]: OR, 2.68; 95% CI, 1.20-5.99), psychiatric illness (UC: OR, 2.08; 95% CI, 1.03-4.19), opiates (CD: OR, 5.61; 95% CI, 2.67-11.82; UC: OR, 5.14; 95% CI, 2.52-10.48), prior surgery (CD: OR, 3.29; 95% CI, 1.59-6.82; UC: OR, 2.72; 95% CI, 1.39-5.32), penetrating CD (OR, 3.29; 95% CI, 1.02-10.62), and corticosteroid requirement (CD: OR, 3.78; 95% CI, 1.86-7.65; UC: OR, 2.98; 95% CI, 1.51-5.90) remained independently associated with high charges. Conclusions: High expenditure IBD patients were affected by more severe disease. The high prevalence of depression, anxiety, and chronic pain in these patients suggests the need for focused treatment of these comorbidities ultimately to reduce financial burden.

Original languageEnglish (US)
Pages (from-to)1442-1449
Number of pages8
JournalInflammatory bowel diseases
Issue number6
StatePublished - Jun 1 2016


  • cost
  • depression
  • inflammatory bowel disease
  • superuser

ASJC Scopus subject areas

  • Immunology and Allergy
  • Gastroenterology


Dive into the research topics of 'Demographic and clinical predictors of high healthcare use in patients with inflammatory bowel disease'. Together they form a unique fingerprint.

Cite this